Tumor Stiffness Fingerprinted: Rheology and 3D Spheroids Map Breast Cancer Mechanics

Breast cancer remains the most frequently diagnosed malignancy among women worldwide, and while survival has improved dramatically for localized tumors, metastatic disease still accounts for more than 90 percent of breast cancer deaths. For decades, oncology research has focused overwhelmingly on the molecular and genetic signatures of tumors. Now, a growing body of evidence suggests that another dimension of cancer biology has been quietly shaping the disease all along: mechanics. A new study published in Bioengineering & Translational Medicine presents a multimodal experimental framework that measures the viscoelastic properties of healthy and malignant breast tissues, using mechanical behavior itself as a fingerprint to distinguish tumor from healthy tissue.

The research, led by Federica Banche-Niclot, Rosalia Ferraro, Francesca Taraballi, and Sergio Caserta across institutions in the United States and Italy, addresses a persistent gap in translational cancer research. Mechanical alterations within the tumor microenvironment, including stiffening of the extracellular matrix, altered tissue viscoelasticity, and increased cellular deformability, are not passive byproducts of disease. Instead, these biomechanical cues actively reshape cellular behavior, influencing how cancer cells invade, migrate, survive under stress, and respond to chemotherapy. Yet despite this recognized importance, mechanical phenotype remains underutilized in diagnostic and therapeutic workflows, and few platforms exist that allow controlled, quantitative exploration of these mechanical dynamics.

Conventional tools for studying tissue mechanics have significant limitations. Atomic force microscopy, indentation, micro tweezers, and compression assays have all contributed valuable insights into cellular elasticity, but they often oversimplify the inherently viscoelastic nature of biological systems. These techniques are sensitive to tool geometry and substrate properties, producing high variability and limited comparability, especially when moving from isolated cells to tissue-level constructs. The new study instead places rotational rheology at the center of its strategy. By measuring the elastic storage modulus G-prime and the viscous loss modulus G-double-prime, rheology captures both energy storage and dissipation, the key parameters governing how tumors deform, resist, or transmit mechanical stress. These moduli can be converted into conventional metrics such as Young’s modulus under defined assumptions, enabling comparisons across biological models.

To build a physiologically relevant in vitro system, the team cultured two distinct cell lines as three-dimensional spheroids using the liquid overlay technique. Cancer spheroids were formed from MDA-MB-231 human breast adenocarcinoma cells, a line derived from a patient with metastatic disease, while non-tumoral spheroids were formed from primary human mesenchymal stem cells isolated from infrapatellar fat pad tissue under institutionally approved protocols. Spheroids were grown in U-bottom 96-well plates coated with a nonstick polyHEMA film, which promotes cell-to-cell aggregation. Viability was tracked over 72 hours using an ATP-based metabolic assay alongside live/dead fluorescent staining. The mesenchymal spheroids developed a necrotic core by 72 hours, so they were mechanically tested at 24 hours, whereas the cancer spheroids reached a compact, nearly spherical morphology with sustained viability at 72 hours and were tested at that timepoint.

A critical design challenge was how to hold the spheroids in place during rheological measurement without contaminating the mechanical signal. The researchers embedded the spheroids in a purified methacrylated Type I bovine collagen hydrogel at 3 milligrams per milliliter, cast into disks matching the 25-millimeter rheometer plate. Spheroid numbers were calculated to achieve roughly 1 percent surface coverage of the supporting disk, requiring 15 cancer spheroids or 85 mesenchymal spheroids per sample. The bare collagen gel proved to be approximately three orders of magnitude softer than the spheroid-laden constructs, with a storage modulus of only about 78 pascals at an angular frequency near 1 radian per second, confirming that the support matrix did not mask the mechanics of the cells themselves.

The rheological results revealed a striking mechanical contrast. At an angular frequency of about 1 radian per second, the storage modulus reached 9.70 plus or minus 1.83 times 10 to the fourth pascals for constructs containing healthy spheroids and 2.45 plus or minus 1.13 times 10 to the fifth pascals for those containing cancer spheroids, a 2.5-fold difference in stiffness. The loss tangent, the ratio of viscous to elastic response, stayed nearly constant at around 0.30 for healthy constructs and 0.15 for tumoral ones, indicating that the cancer spheroids behaved in an even more solid-like fashion. Converting the storage moduli into Young’s modulus values assuming incompressible behavior yielded approximately 2.91 times 10 to the fifth pascals for healthy constructs and 7.36 times 10 to the fifth pascals for tumoral constructs. This stiffening is consistent with the extracellular matrix remodeling, increased collagen crosslinking, and heightened contractile forces that characterize aggressive cancer phenotypes and promote migration and invasion.

To validate the in vitro platform against real biology, the team benchmarked it with ex vivo tissues: healthy mammary gland fat pads from mice and tumor masses generated by injecting MDA-MB-231 cells into mice. Tissues were rehydrated in phosphate-buffered saline and standardized to 5-millimeter cylinders with a biopsy punch. Rheological testing showed the same directional pattern as the spheroid models, with tumoral tissues approximately ten times stiffer than healthy counterparts, exhibiting storage moduli of 2.38 plus or minus 1.04 times 10 to the fifth pascals versus 2.45 plus or minus 0.93 times 10 to the fourth pascals. Both tissue types displayed solid-like behavior, with the storage modulus consistently exceeding the loss modulus across the tested frequency range of 0.01 to 100 radians per second.

One of the study’s most technically important findings emerged from comparing rheology with compression testing. Compression measurements using a Hertz model analysis of the stress-strain curve, restricted to strains below 10 percent to remain in the linear elastic regime, gave Young’s modulus values of 3.68 plus or minus 0.38 times 10 to the fourth pascals for healthy tissue and 5.22 plus or minus 0.62 times 10 to the fourth pascals for tumoral tissue, making tumors about 1.42 times stiffer. These absolute values differed from the rheological estimates, but the discrepancy was resolved when the applied normal force was taken into account. Healthy tissues exhibited force-softening, with moduli decreasing by at least an order of magnitude as normal force increased, while tumoral tissues showed force-stiffening, with moduli rising under higher load. When rheological values were compared within the same normal force window reached during compression, roughly 0.1 to 0.15 newtons, the two methods agreed closely. The authors emphasize that this nonlinear, force-dependent behavior can introduce serious artifacts into biomechanical characterization if not standardized, and that mechanical comparisons must be made within consistent force regimes.

The translational implications are considerable. Increased tumor stiffness is known to hinder drug diffusion, impair immune cell infiltration, and activate mechanotransduction pathways that promote chemoresistance. By reproducing this stiffness landscape in vitro and aligning it with ex vivo profiles, the platform enables a more predictive evaluation of mechanically responsive therapies before animal or clinical testing. The authors also point toward mechanical fingerprinting as a potential physical biomarker strategy, particularly if integrated with imaging techniques or functional assays. The standardized hydrogel scaffolds, controlled spheroid assembly, and quantitative mechanical outputs make the approach suitable not only for academic investigation but also for industrial drug screening and biomaterials testing pipelines.

The researchers are careful to note the limitations and the road ahead. Bulk rheological metrics provide standardization and throughput, but they cannot fully describe the mechanical microenvironment experienced by individual cells, which varies spatially due to heterogeneity in matrix density and local architecture. Cell-scale techniques such as atomic force microscopy and microrheology capture local stiffness gradients relevant to mechanotransduction but require careful model assumptions and are sensitive to sampling location, so bulk and microscale measurements should be treated as complementary rather than competing descriptors. Future work will expand the platform to larger ex vivo cohorts, incorporate additional cell populations and tumor subtypes, add dynamic cues such as perfusion and immune components, and account for sex as a biological variable, since hormone-dependent signaling can modulate stromal behavior and matrix remodeling. Mycoplasma testing was not performed in this proof-of-concept study, though no morphological abnormalities or altered growth kinetics were observed. Even so, the framework establishes a reproducible mechanical benchmark for breast cancer, laying the groundwork for embedding biomechanical profiling into preclinical workflows, mechanics-informed diagnostics, and patient-specific modeling.

Subject of Research: Viscoelastic biomechanical profiling of healthy and cancerous breast tissue using 3D spheroid models and ex vivo rheology

Article Title: Mechanical fingerprints in breast cancer research: A multimodal experimental approach

Article References: Banche‐Niclot, F., Ferraro, R., Di Palo, V., de Paolis, P., Taraballi, F., & Caserta, S. (2026). Mechanical fingerprints in breast cancer research: A multimodal experimental approach. Bioengineering & Translational Medicine, 11(5), Article e70148. https://doi.org/10.1002/btm2.70148

Image Credits: AI Generated

DOI: 10.1002/btm2.70148

Keywords: breast cancer, tumor biomechanics, rheology, 3D spheroids, viscoelasticity, extracellular matrix, tumor stiffness, Young's modulus, compression testing, drug delivery, mechanotransduction, ex vivo tissue analysis